Financhill
Back

Cytokinetics Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
45

CYTK
Cytokinetics

Last Price:
64.35
Seasonality Move:
12.64%
Sell
43

MDGL
Madrigal Pharmaceuticals

Last Price:
215.99
Seasonality Move:
-4.02%
Sell
45
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $63.37. The Score for CYTK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $210.08. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $63.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $210.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2 Sell
Relative Strength Index (14 RSI): 39.34 Sell
Chaikin Money Flow: 446915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.12 - 72.68) Sell
Bollinger Bands (100): (55.2 - 85.66) Sell

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.96 Sell
Relative Strength Index (14 RSI): 41.16 Sell
Chaikin Money Flow: 3368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (209.12 - 250.62) Sell
Bollinger Bands (100): (212.99 - 251.91) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.51 Sell
20-day SMA: 68.3 Sell
50-day SMA: 69.18 Sell
200-day SMA: 51.66 Buy
8-day EMA: 64.44 Sell
20-day EMA: 66.78 Sell
50-day EMA: 68.53 Sell
200-day EMA: 57.55 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 204.94 Buy
20-day SMA: 223.79 Sell
50-day SMA: 240.98 Sell
200-day SMA: 201.27 Buy
8-day EMA: 207.54 Buy
20-day EMA: 219.87 Sell
50-day EMA: 229.81 Sell
200-day EMA: 215.91 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.71 per share, a decrease this year of $4.24 per share, and an increase next year of $8.97 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):